Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 30.50B | 27.32B | 25.79B | 23.35B | 20.27B |
Gross Profit | 4.26B | 4.47B | 5.06B | 4.88B | 3.50B |
EBITDA | 1.50B | 2.08B | 2.69B | 2.55B | 1.55B |
Net Income | 880.15M | 1.26B | 1.74B | 1.62B | 934.82M |
Balance Sheet | |||||
Total Assets | 31.29B | 26.85B | 27.43B | 24.44B | 20.56B |
Cash, Cash Equivalents and Short-Term Investments | 7.25B | 6.87B | 4.79B | 5.49B | 5.54B |
Total Debt | 18.67B | 14.63B | 15.64B | 13.40B | 11.18B |
Total Liabilities | 19.79B | 15.77B | 17.12B | 15.21B | 12.46B |
Stockholders Equity | 11.49B | 11.08B | 10.30B | 9.23B | 8.10B |
Cash Flow | |||||
Free Cash Flow | -3.11B | 3.57B | -2.34B | -1.56B | 1.00B |
Operating Cash Flow | -1.60B | 4.55B | -706.53M | -1.28B | 2.75B |
Investing Cash Flow | -1.62B | -1.25B | -1.55B | -434.60M | -1.75B |
Financing Cash Flow | 3.54B | -1.50B | 1.58B | 1.67B | 905.75M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥10.90B | 5.69 | 3.17% | 11.78% | 131.36% | ||
74 Outperform | ¥8.91B | 4.47 | 4.29% | 7.57% | 66.62% | ||
72 Outperform | ¥10.61B | 9.32 | 4.92% | 23.20% | 3.21% | ||
70 Outperform | ¥8.87B | 27.06 | ― | 341.55% | -0.36% | ||
67 Neutral | ¥9.84B | 40.59 | 4.04% | 3.88% | -87.10% | ||
57 Neutral | ¥6.92B | 114.71 | ― | 42.72% | -110.19% | ||
53 Neutral | $1.23B | 2.78 | -5.63% | 5.74% | -4.29% | -97.75% |